Open access peer-reviewed chapter

3D Modeling of a Natural Killer Receptor, Siglec-7: Critical Amino Acids for Glycan-Binding and Cell Death-Inducing Activity

By Toshiyuki Yamaji, Yoshiki Yamaguchi, Motoaki Mitsuki, Shou Takashima, Satoshi Waguri, Yasuhiro Hashimoto and Kiyomitsu Nara

Submitted: March 27th 2011Reviewed: June 27th 2011Published: March 7th 2012

DOI: 10.5772/31157

Downloaded: 1533

© 2012 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Toshiyuki Yamaji, Yoshiki Yamaguchi, Motoaki Mitsuki, Shou Takashima, Satoshi Waguri, Yasuhiro Hashimoto and Kiyomitsu Nara (March 7th 2012). 3D Modeling of a Natural Killer Receptor, Siglec-7: Critical Amino Acids for Glycan-Binding and Cell Death-Inducing Activity, Modeling and Simulation in Engineering, Catalin Alexandru, IntechOpen, DOI: 10.5772/31157. Available from:

chapter statistics

1533total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Applications of Computational 3D–Modeling in Organismal Biology

By Christian Laforsch, Hannes Imhof, Robert Sigl, Marcus Settles, Martin Heß and Andreas Wanninger

Related Book

First chapter

Introductory Chapter: Petri Nets in Science and Engineering

By Raul Campos-Rodriguez and Mildreth Alcaraz-Mejia

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More about us